Cell and gene therapy approvals in Japan and the need for international harmonization

Nat Biotechnol. 2024 Jan;42(1):13-17. doi: 10.1038/s41587-023-02053-7.

Authors

Teruyo Arato^{1

2}, Kaori Nomura^{3

4}

Affiliations

¹ Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan. arato@med.hokudai.ac.jp.
² Hokkaido University Graduate School of Medicine, Department of Regulatory Science, Sapporo, Japan. arato@med.hokudai.ac.jp.
³ Teikyo Heisei University, Faculty of Pharmaceutical Sciences, Tokyo, Japan.
⁴ Fukushima Medical University, Advanced Clinical Research Center, Fukushima, Japan.

PMID: 38191662
DOI: 10.1038/s41587-023-02053-7

No abstract available

Publication types

Letter

MeSH terms

Drug Industry*
International Cooperation*
Japan